tiprankstipranks
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market
RNTX
Rein Therapeutics
RESEARCH TOOLSreports

Rein Therapeutics (RNTX) Income Statement

1,206 Followers

Rein Therapeutics Income Statement

Last quarter (Q4 2025), Rein Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Rein Therapeutics's net income was $-31.97M. See Rein Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 21.93M$ 65.11M$ 16.28K$ 27.65K$ 26.61K
Depreciation and Amortization
$ 1.00K$ 63.00K$ 119.00$ 169.00$ 121.00
EBITDA
$ -21.93M$ -28.05M$ -15.23K$ -27.48K$ -26.48K
Operating Income
$ -21.93M$ -65.11M$ -16.28K$ -27.65K$ -26.61K
Other Income/Expenses
$ -28.65M$ 800.00K$ 544.00$ 318.00$ 441.00
Pretax Income
$ -50.58M$ -64.31M$ -15.73K$ -27.33K$ -26.16K
Net Income
$ -49.87M$ -62.88M$ -15.73K$ -27.33K$ -26.16K
Per Share Metrics
Basic EPS
$ -1.96$ -3.51$ -3.42$ -6.02$ -5.89
Diluted EPS
$ -1.96$ -3.51$ -3.42$ -6.02$ -5.89
Weighted Average Shares Outstanding
 25.44M 17.94M 4.60M 4.54M 4.44M
Weighted Average Shares Outstanding (Diluted)
 25.44M 17.94M 4.60M 4.54M 4.44M
Currency in USD

Rein Therapeutics Earnings and Revenue History